Free Trial
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

$70.68
+0.28 (+0.40%)
(As of 07/26/2024 ET)
Today's Range
$70.38
$71.78
50-Day Range
$62.62
$71.83
52-Week Range
$56.34
$75.31
Volume
222,395 shs
Average Volume
246,986 shs
Market Capitalization
$3.51 billion
P/E Ratio
16.95
Dividend Yield
N/A
Price Target
$98.25

Prestige Consumer Healthcare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
39.0% Upside
$98.25 Price Target
Short Interest
Bearish
4.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
1.25mentions of Prestige Consumer Healthcare in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.01%
From $4.42 to $4.73 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.49 out of 5 stars

Medical Sector

111th out of 936 stocks

Pharmaceutical Preparations Industry

40th out of 436 stocks

PBH stock logo

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH Stock Price History

PBH Stock News Headlines

How a $0.25 cent option contract makes my top traders feel
If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…
Prestige Consumer Q4 Earnings Miss, Operating Margin Falls
How a $0.25 cent option contract makes my top traders feel
If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…
Prestige Consumer Healthcare Inc.
PBH Mar 2024 55.000 put
PBH Jul 2024 70.000 call
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/08/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
560
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$98.25
High Stock Price Target
$117.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+38.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$209.34 million
Pretax Margin
24.53%

Debt

Sales & Book Value

Annual Sales
$1.13 billion
Cash Flow
$5.01 per share
Book Value
$33.34 per share

Miscellaneous

Free Float
48,880,000
Market Cap
$3.52 billion
Optionable
Optionable
Beta
0.49
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

PBH Stock Analysis - Frequently Asked Questions

How have PBH shares performed this year?

Prestige Consumer Healthcare's stock was trading at $61.22 on January 1st, 2024. Since then, PBH stock has increased by 15.5% and is now trading at $70.68.
View the best growth stocks for 2024 here
.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) issued its quarterly earnings data on Tuesday, May, 14th. The company reported $1.02 earnings per share for the quarter, missing analysts' consensus estimates of $1.14 by $0.12. The company's revenue for the quarter was down 3.1% on a year-over-year basis.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Prestige Consumer Healthcare's major shareholders?

Top institutional investors of Prestige Consumer Healthcare include Allspring Global Investments Holdings LLC (2.66%), Bank of New York Mellon Corp (0.89%), Leeward Investments LLC MA (0.82%) and Raymond James & Associates (0.24%). Insiders that own company stock include Ronald M Lombardi and Mary Beth Fritz.
View institutional ownership trends
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE) and Wells Fargo & Company (WFC).

This page (NYSE:PBH) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners